So-Cheong-Ryong-Tang, tradititional Korean medicine, suppresses Th2 lineage development

Biological and Pharmaceutical Bulletin

Volumn 27, Issue 5, 2004, Pages 739-743

  Ko, Eunjung ^a   Rho, Samwoong ^a   Cho, Chongwoon ^a   Choi, Hyun ^a   Ko, Seonggyu ^a   Lee, Youngwon ^b   Hong, Moo Chang ^a   Shin, Min Kyu ^a   Jung, Seung Gi ^c   Bae, Hyunsu ^a  

^a Kyung Hee University   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c Chungnoi Clinical Research Institute   (South Korea)

Author keywords

Interleukin 4; So Cheong Ryong Tang; Th1; Th2

Indexed keywords

6 GINGEROL; ALPHA ASARONE; ANTIASTHMATIC AGENT; CINNAMALDEHYDE; GINGEROL; GLYCYRRHIZIC ACID; HOMOGENTISIC ACID; PAEONIFLORIN; SCHIZANDRIN; SO CHEONG RYONG TANG; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR C MAF; TRANSCRIPTION FACTOR GATA 3; UNCLASSIFIED DRUG; GROWTH INHIBITOR; HERBACEOUS AGENT; IMMUNOSUPPRESSIVE AGENT; SHO SEIRYU TO; SHO-SEIRYU-TO;

ALLERGIC ASTHMA; ANIMAL CELL; ARTICLE; CELL LINEAGE; CELL MATURATION; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; GENE EXPRESSION REGULATION; KOREA; MOUSE; NONHUMAN; POLARIZATION; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN FUNCTION; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH2 CELL; TRADITIONAL MEDICINE; ANIMAL; BAGG ALBINO MOUSE; CHINESE MEDICINE; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECT; IMMUNOLOGY; ISOLATION AND PURIFICATION;

ANIMALS; CELL LINEAGE; DRUGS, CHINESE HERBAL; FEMALE; GROWTH INHIBITORS; IMMUNOSUPPRESSIVE AGENTS; KOREA; MEDICINE, KAMPO; MICE; MICE, INBRED BALB C; TH2 CELLS;

EID: 16644394337     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.27.739     Document Type: Article

References (22)

1. Mosmann T. R., Cherwinski H., Bond M. W., Giedlin M. A., Coffman R. L., J. Immunol., 136, 2348-2357 (1986).
2. Szabo S. J., Kim S. T., Costa G. L., Zhang X., Fathman C. G., Glimcher L. H., Cell, 100, 655-669 (2000).
3. Fiorentino D. F., Bond M. W., Mosmann T. R., J. Exp. Med., 170, 2081-2095 (1989).
4. Swain S. L., Weinberg A. D., English M., Huston G., J. Immunol., 145, 3796-3806 (1990).
5. Mullen A. C., High F. A., Hutchins A. S., Lee H. W., Villarino A. V., Livingston D. M., Kung A. L., Cereb N., Yao T. P., Yang S. Y., Reiner S. L., Science, 292, 1907-1910 (2001).
6. Das J., Chen C. H., Yang L., Cohn L., Ray P., Ray A., Nat. Immunol., 2, 45-50 (2001).
7. Rincon M., Flavell R. A., Curr. Biol., 7, R729-R732 (1997).
8. Abbas A. K., Murphy K. M., Sher A., Nature (London), 383, 787-793 (1996).
9. Rao A., Avni O., Br. Med. Bull., 56, 969-984 (2000).
10. Robinson D. S., Hamid Q., Ying S., Tsicopoulos A., Barkans J., Bentley A. M., Corrigan C., Durham S. R., Kay A. B., N. Engl. J. Med., 326, 298-304 (1992).
11. Lebrec H., Kerdine S., Gaspard I., Pallardy M., Toxicology, 158, 25-29 (2001).
12. Gajewski T. F., Schell S. R., Nau G., Fitch F. W., Immunol. Rev., 111, 79-110 (1989).
13. Sakaguchi M., Mase A., Iizuka A., Yuzurihara M., Ishige A., Amagaya S., Komatsu Y., Takeda H., Matsumiya T., Methods Find. Exp. Clin. Pharmacol., 19, 707-713 (1997).
14. Kao S. T., Wang S. D., Wang J. Y., Yu C. K., Lei H. Y., Allergy, 55, 1127-1133 (2000).
15. Yang S. H., Hong C. Y., Yu C. L., Int. Immunopharmacol., 1, 1173-1182 (2001).
16. Tanaka A., Ohashi Y., Kakinoki Y., Washio Y., Yamada K., Nakai Y., Nakano T., Ohmoto Y., Acta Otolaryngol. Suppl., 538, 118-125 (1998).
17. Ko E., Rho S., Lee E., Seo Y., Cho C., Shin M., Hong M., Bae H., J. Ethnopharmacol., in revision (2003).
18. Nakamura Y., Ghaffar O., Olivenstein R., Taha R. A., Soussi-Gounni A., Zhang D. H., Ray A., Hamid Q., J. Allergy Clin. Immunol., 103, 215-222 (1999).
19. Nakamura Y., Christodoulopoulos P., Cameron L., Wright E., Lavigne F., Toda M., Muro S., Ray A., Eidelman D. H., Minshall E., Hamid Q., J. Allergy Clin. Immunol., 105, 1146-1152 (2000).
20. Zhang D. H., Yang L., Cohn L., Parkyn L., Homer R., Ray P., Ray A., Immunity, 11, 473-482 (1999).
21. Ho I. C., Hodge M. R., Rooney J. W., Glimcher L. H., Cell, 85, 973-983 (1996).
22. Kim J. I., Ho I. C., Grusby M. J., Glimcher L. H., Immunity, 10, 745-751 (1999).